Ophthalmic Portfolio
Micromedic
Management – DiagnosTear
Ronen Shoushan
CEO DiagnosTear (B.Sc.)
Ronen Shoushan is an experienced and skilled entrepreneur and executive. In his thirteen years in high tech, he has served in a variety of leadership positions in R&D, business development, marketing, and sales.
Before joining DiagnosTear as the CEO in 2017, Ronen was the CEO and founder of D.R.S-Solar, a company that develops and sells products in the renewable energy market.
Ronen leveraged his medical devices expertise to lead a variety of startups from their early incubation stages, including OrthoMediTec, which specializes in orthopedic trauma care and SafeBack ReEntry Medical, which focuses on vascular surgery.
Ronen graduated with a B.Sc. degree in Bio-Medical Engineering from Ben-Gurion University, Israel and serves as a major (in reserve) in the Israeli Air Force.
Dr. Eran Eilat
CSO DiagnosTear
M.D, Ph.D,
A serial entrepreneur who has founded several biotechnology and medical device companies including, Otic Pharma, a developer of unique drug delivery technology for delivering drugs to the ears, which completed a successful phase II clinical trial, and closed a significant financing round led by Orbimed, and AOPharma, which has developed a proprietary preservative free, multi-dose and user-friendly ophthalmic drug delivery device.
Dr. Eilat received an M.D. degree from the Sackler School of Medicine in Tel Aviv University, and a Ph.D. degree in Immunology from the Weizmann Institute of Science. He is the inventor of numerous patents in the medical and biotechnology fields.
TeaRx™
Back to Ophthalmic Portfolio
© BioLight Life Sciences Ltd.
Site Development Site2goal | Design Telescope